[Administration of intravenous immunoglobulin is not free of risk in the neonatal period].

Subjects

Subjects :

Erythroblastosis, Fetal drug therapy
Humans
Infant, Newborn
Infusions, Intravenous
Phototherapy
Risk Factors
Colitis, Ulcerative chemically induced
Immunization, Passive adverse effects
Infant, Premature, Diseases drug therapy
Intensive Care Units, Neonatal
Jaundice, Neonatal drug therapy

Details

Language :

French

ISSN :

1769-664X

Volume :

17

Issue :

3

Database :

MEDLINE

Journal :

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Publication Type :

Editorial & Opinion

Accession number :

20097548

Full Text :

https://doi.org/10.1016/j.arcped.2009.11.026